GHK-Cu Study Published in Biomaterials Advances
A new publication on GHK-Cu appeared in Biomaterials Advances on 2026-11-01, examining poly(γ-benzyl-L-glutamate) microsphere structures and osteogenic-angiogenic coupling responses.
Read Full ArticleAll News
Semaglutide Study on Alcohol Use Disorder Published in Annals
A new publication dated Aug 4, 2026 in Annals of Internal Medicine reports on weekly semaglutide in alcohol use disorder with comorbid obesity.
Efpeglenatide Featured in New GLP-1 Cardiovascular Outcomes Meta-Analysis
A systematic review and network meta-analysis on GLP-1-based therapies and cardiovascular outcomes in type 2 diabetes, including efpeglenatide, published August 1, 2026 in Diabetes, Obesity & Metabolism.
Albiglutide Cited in New Meta-Analysis on GLP-1 Timing and Pregnancy
A systematic review and meta-analysis published in Endocrine on July 31, 2026 examined GLP-1 receptor agonist timing, including albiglutide, and hypertensive disorders of pregnancy.
Cerebrolysin Cited in New Post-Stroke Neuro-Recovery Publication
A new publication dated July 29, 2026, in Cerebrovascular Diseases Extra addresses research-evidence-practice gaps in post-stroke pharmacological therapies in Asia, referencing cerebrolysin.
BPC-157 Featured in New Analytical Workflow Study for Doping Detection
A new publication dated July 27, 2026 in The Analyst describes an analytical workflow for detecting peptidic and non-peptidic doping agents, including BPC-157.
New Publication on Humanin Analog HNG in Diabetic Nephropathy Research
A new study on S14G-humanin (HNG) was published July 23, 2026 in European Journal of Pharmacology, examining tubular injury pathways in diabetic nephropathy.
TB-500 Studied With BPC-157 in Rat Achilles Tendon Healing
A new publication examined TB-500 and BPC-157 effects on Achilles tendon healing in rats, published in Joint Diseases and Related Surgery on 2026-07-23.
New Publication Characterizes Bremelanotide Acetate Degradants via LC-HRMS/MS
A study published July 22, 2026 in Analytical Methods details LC-HRMS/MS characterization of bremelanotide acetate and its degradants.
Humanin Study Published in Reproductive Biology on SSRI Effects
A new publication on humanin, an unapproved research compound, appeared in Reproductive Biology on July 21, 2026, examining SSRI-treated male rats.
Macimorelin Study Published in The Lancet on Heart Failure Trial
A new publication dated July 18, 2026 in The Lancet reports on the GOAL-HF1 phase 1b/2a study of the oral ghrelin receptor agonist in reduced ejection fraction heart failure.
GHRP-6 Featured in Phase III Stroke Trial Publication
A new publication dated July 16, 2026 details a Phase III trial of GHRP-6 and epidermal growth factor in acute ischemic stroke patients.
Melanotan I Study on NDP-MSH in Membranous Nephropathy Model Published
A new publication dated July 15, 2026 in The FASEB Journal reports on NDP-MSH, a synthetic melanocortin agonist, in a mouse model of THSD7A-associated membranous nephropathy.
New Publication on Thymosin Beta-4 in BV2 Microglial Cell Study
A new publication dated July 15, 2026 examines thymosin beta-4 and pyroptosis in BV2 microglial cells, published in a Chinese pediatrics journal.
Afamelanotide-related Study on Stereocomplexed Peptide Hydrogels Published
A new publication dated July 10, 2026 in Journal of Controlled Release details heterochiral co-assembly of stereocomplexed peptide hydrogels for drug delivery.
Albiglutide Featured in New Network Meta-Analysis Publication
A new publication dated July 9, 2026 in Diabetes, Obesity & Metabolism includes albiglutide in a disease-stratified network meta-analysis on SGLT2 inhibitors and GLP-1 receptor agonists.
Tesamorelin Trial Protocol Published in BMJ Open
A new publication describes the TRIUMPH clinical trial protocol testing tesamorelin as an adjunct to exercise for physical function in HIV, published July 8, 2026.
New Publication on EGF and GHRP-6 in Preclinical Cognitive Study
A new preclinical publication on EGF and GHRP-6 co-administration appeared in Neurotoxicity Research on July 4, 2026, per PubMed listing.
New Publication on FOXO4-DRI: Redox Regulation and Senescence Study
A new study on FOXO4-DRI titled 'FOXO4 as a Redox-Sensitive Regulator...' was published in Antioxidants (Basel, Switzerland) on July 3, 2026.
Sermorelin: Case Report on Cervical Osteophyte Dysphagia Published
A new case report published July 3, 2026 in Frontiers in Surgery discusses anterior cervical osteophyte-related dysphagia in a long-term growth hormone user.
FOXO4-DRI Referenced in New Glioblastoma Senescence Publication
A study titled "Acylglycerol Kinase Sensitizes Glioblastoma to Temozolomide via Limiting Mitochondrial Damage Related Cellular Senescence" was published in Molecular Carcinogenesis on July 2, 2026.